50
Views
5
CrossRef citations to date
0
Altmetric
Review

Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy

, , , , , , , & show all
Pages 4599-4605 | Published online: 15 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stig E. Andersen, Ida B. Andersen, Benny V. Jensen, Per Pfeiffer, Takayo Ota & Jim S. Larsen. (2019) A systematic review of observational studies of trifluridine/tipiracil (TAS-102) for metastatic colorectal cancer. Acta Oncologica 58:8, pages 1149-1157.
Read now
Julia Martinez-Perez, M. Carmen Riesco-Martinez & Rocio Garcia-Carbonero. (2018) The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer. Expert Opinion on Drug Safety 17:6, pages 643-650.
Read now

Articles from other publishers (3)

Daniel Sur, Cristina Lungulescu, Ștefan Spînu, Alecsandra Gorzo, Elena-Adriana Dumitrescu, Dan Ionut Gheonea & Cristian-Virgil Lungulescu. (2022) Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis. Frontiers in Pharmacology 13.
Crossref
Takuro Mizukami, Naoki Izawa, Takako Eguchi Nakajima & Yu Sunakawa. (2019) Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives. Drugs 79:6, pages 633-645.
Crossref
Erika Cecchin, Elena De Mattia, Fabrizio Ecca & Giuseppe Toffoli. (2018) Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Drug Resistance Updates 39, pages 18-40.
Crossref